Schedule 13D ownership disclosure
LogicBio Therapeutics, Inc.
Security class unavailable · CUSIP: 54142F102
Event date: 2020-11-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.2500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-307898
- Form type
- SC 13D
- Filer
- Arix Bioscience plc
- CIK
- CIK 1700449
- Filed
- Oct 26, 2021
- Reporting period
- Nov 09, 2020
- Description
- Schedule 13D beneficial ownership